B

Bicara Therapeutics

18 employees

Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Targeted Oncology

Immunotherapy

Therapeutics

Biopharma

Drug Discovery

Life Science

Date founded

2020

Funding rounds raised

Total raised

$108M

from 8 investors over 8 rounds

B

Bicara Therapeutics raised $108M on March 6, 2023

Investors: Omega Funds, Bioqube Ventures, RA Capital Management, L.P., Red Tree Venture Capital, The Invus Group, Premji Invest and F-Prime Capital Partners

B

Bicara Therapeutics raised $40M on March 15, 2021

Investors: Biocon